CATALYST BIOSCIENCES, INC. (231) | Business Finance (13)

Browse by Subcategory

Equity Distribution Agreements (1 contract)
Purchase Agreements (3)
Stock Agreements (3)
Underwriting Agreements (3)
Waiver Agreements (3)

Recent Contracts

Contingent Value Rights Agreement, dated as of December 26, 2022, between Catalyst and American Stock Transfer & Trust Company, LLC (Filed With SEC on May 15, 2023)
Waiver Agreement between Catalyst Biosciences, Inc. and Dr. Nassim Usman, dated January 17, 2023 (Filed With SEC on May 15, 2023)
Waiver Agreement between Catalyst Biosciences, Inc. and Dr. Grant Blouse, dated January 14, 2023 (Filed With SEC on May 15, 2023)
Waiver Agreement between Catalyst Biosciences, Inc. and Ms. Seline Miller, dated January 17, 2023 (Filed With SEC on May 15, 2023)
Agreement and Amendment to Asset Purchase Agreement, dated as of March 29, 2023, by and among Catalyst, GNI Group and GNI HK (Filed With SEC on March 30, 2023)
Asset Purchase Agreement dated as of February 27, 2023 by and between Catalyst Biosciences, Inc. and GC Biopharma Corp (Filed With SEC on March 2, 2023)
Asset Purchase Agreement, dated December 26, 2022, by and among Catalyst Biosciences, Inc., GNI Group Ltd., and GNI Hong Kong Limited (Filed With SEC on December 27, 2022)
Form of Stock Option Award Agreement (Filed With SEC on March 31, 2022)
Equity Distribution Agreement, dated as of October 15, 2021, between Catalyst Biosciences, Inc. and Piper Sandler & Co (Filed With SEC on October 15, 2021)
Form of Stock Option Award Agreement (Filed With SEC on March 4, 2021)
Underwriting Agreement, dated January 26, 2021, by and between Catalyst Biosciences, Inc. and Piper Sandler & Co., as representative of the several Underwriters named therein (Filed With SEC on January 27, 2021)
Underwriting Agreement, dated June 18, 2020, by and between Catalyst Biosciences, Inc. and Raymond James & Associates, Inc., as representative of the several Underwriters named... (Filed With SEC on June 19, 2020)
Underwriting Agreement, dated February 13, 2020, by and between Catalyst Biosciences, Inc. and Raymond James & Associates, Inc., as representative of the several Underwriters... (Filed With SEC on February 14, 2020)